Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?
(143)
Brandes, Alba A
a
Franceschi, Enrico
a
Ermani, Mario
b
Tosoni, Alicia
a
Albani, Fiorenzo
c,d
Depenni, Roberta
e
Faedi, Marina
f
Pisanello, Anna
g
Crisi, Girolamo
h
Urbini, Benedetta
i
Dazzi, Claudio
j
Cavanna, Luigi
k
Mucciarini, Claudia
l
Pasini, Giuseppe
m
Bartolini, Stefania
a
Marucci, Gianluca
d
Morandi, Luca
d
Zunarelli, Elena
e
Cerasoli, Serenella
n
Gardini, Giorgio
g
Lanza, Giovanni
o
Silini, Enrico Maria
h
Cavuto, Silvio
g
Baruzzi, Agostino
c,d
Calbucci, F
c
D'Alessandro, R
c
Michelucci, R
c
Eusebi, V
a
Ceruti, S
p
Fainardi, E
p
Tamarozzi, R
p
Emiliani, E
q
Cavallo, M
p
Fiorica, F
p
Valentini, A
r
Sasso, E
s
Biasini, C
t
Guidetti, D
t
Marcello, N
g
Cremonini, A M
n
Guiducci, G
n
de Pasqua, S
c
Testoni, S
c
Agati, R
u
Ambrosetto, G
u
Bacci, A
u
Baldin, E
u
Baldrati, A
u
Barbieri, E
u
Bellavista, E
u
Bisulli, F
u
Bonora, E
u
Bunkheila, F
u
Carelli, V
u
Crisci, M
u
Dall'Occa, P
u
de Biase, D
u
Ferro, S
u
Franceschi, C
u
Frezza, G
u
GrassoV ,
u
Leonardi, M
u
Mazzocchi, V
u
Mostacci, B
u
Palandri, G
u
Pasini, E
u
Pastore Trossello, M
u
Pession, A
u
Ragazzi, M
u
Riguzzi, P
u
Rinaldi, R
u
Rizzi, S
u
Romeo, G
u
Spagnolli, F
u
Tinuper, P
u
Trocino, C
u
Dall'Agata, M
u
Frattarelli, M
u
Gentili, G
u
Giovannini, A
u
Iorio, P
u
Pasquini, U
u
Galletti, G
u
Guidi, C
u
Neri, W
u
Patuelli, A
u
Strumia, S
u
Casmiro, M
u
Gamboni, A
u
Rasi, F
u
Cruciani, G
v
Cenni, P
u
Guidi, A R
u
Zumaglini, F
u
Amadori, A
u
Pasquinelli, M
u
Pasquini, E
u
Polselli, A
u
Ravasio, A
u
Viti, B
u
Sintini, M
w
Ariatti, A
u
Bertolini, F
u
Bigliardi, G
u
Carpeggiani, P
u
Cavalleri, F
u
Meletti, S
u
Nichelli, P
u
Pettorelli, E
u
Pinna, G
u
Artioli, F
x
Bernardini, I
x
Costa, M
x
Greco, G
x
Guerzoni, R
x
Stucchi, C
x
Iaccarino, C
u
Rizzi, R
u
Zuccoli, G
u
Api, P
u
Cartei, F
u
Fallica, E
u
Granieri, E
u
Latini, F
u
Lelli, G
u
Monetti, C
u
Ramponi, V
u
Saletti, A
u
Schivalocchi, R
u
Seraceni, S
u
Tola, M R
u
Giorgi, C
y
Montanari, E
y
CerastiD ,
u
Crafa, P
u
DascolaI ,
u
FlorindoI ,
u
MazzaS ,
u
Servadei, F
u
Torelli, P
u
Immovilli, P
u
Morelli, N
u
Vanzo, C
u
more..
|
-
1
-
-
84862016066
-
Epidemiology of glial and non-glial brain tumours in Europe
-
Crocetti E, Trama A, Stiller C, et al. Epidemiology of glial and non-glial brain tumours in Europe. Eur J Cancer. 2012;48(10):1532-1542.
-
(2012)
Eur J Cancer
, vol.48
, Issue.10
, pp. 1532-1542
-
-
Crocetti, E.1
Trama, A.2
Stiller, C.3
-
2
-
-
65349121788
-
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
-
Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459-466.
-
(2009)
Lancet Oncol
, vol.10
, Issue.5
, pp. 459-466
-
-
Stupp, R.1
Hegi, M.E.2
Mason, W.P.3
-
3
-
-
20044366163
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
-
Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-996.
-
(2005)
N Engl J Med
, vol.352
, Issue.10
, pp. 987-996
-
-
Stupp, R.1
Mason, W.P.2
van den Bent, M.J.3
-
4
-
-
84878331540
-
Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in Spain
-
Graus F, Bruna J, Pardo J, et al. Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in Spain. Neuro Oncol. 2013;15(6):797-805.
-
(2013)
Neuro Oncol
, vol.15
, Issue.6
, pp. 797-805
-
-
Graus, F.1
Bruna, J.2
Pardo, J.3
-
5
-
-
84863562673
-
Glioblastoma survival in the United States before and during the temozolomide era
-
Johnson DR, O'Neill BP. Glioblastoma survival in the United States before and during the temozolomide era. J Neurooncol. 2011; 107(2):359-364.
-
(2011)
J Neurooncol
, vol.107
, Issue.2
, pp. 359-364
-
-
Johnson, D.R.1
O'Neill, B.P.2
-
6
-
-
84859530078
-
Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006
-
YabroffKR, Harlan L, Zeruto C, et al. Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006. Neuro Oncol. 2012;14(3):351-359.
-
(2012)
Neuro Oncol
, vol.14
, Issue.3
, pp. 351-359
-
-
Yabroff, K.R.1
Harlan, L.2
Zeruto, C.3
-
7
-
-
0026749893
-
The value of capture-recapture methods even for apparent exhaustive surveys. The need for adjustment for source of ascertainment intersection in attempted complete prevalence studies
-
Hook EB, Regal RR. The value of capture-recapture methods even for apparent exhaustive surveys. The need for adjustment for source of ascertainment intersection in attempted complete prevalence studies. Am J Epidemiol. 1992;135(9):1060-1067.
-
(1992)
Am J Epidemiol
, vol.135
, Issue.9
, pp. 1060-1067
-
-
Hook, E.B.1
Regal, R.R.2
-
8
-
-
33750580929
-
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study
-
Brandes AA, Tosoni A, Cavallo G, et al. Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study. J Clin Oncol. 2006;24(29):4746-4753.
-
(2006)
J Clin Oncol
, vol.24
, Issue.29
, pp. 4746-4753
-
-
Brandes, A.A.1
Tosoni, A.2
Cavallo, G.3
-
9
-
-
84891785971
-
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial
-
Gilbert MR, Wang M, Aldape KD, et al. Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. J Clin Oncol. 2013;31(32):4085-4091.
-
(2013)
J Clin Oncol
, vol.31
, Issue.32
, pp. 4085-4091
-
-
Gilbert, M.R.1
Wang, M.2
Aldape, K.D.3
-
10
-
-
84886591961
-
Glioblastoma management in the temozolomide era: have we improved outcome?
-
Lwin Z, MacFadden D, Al-Zahrani A, et al. Glioblastoma management in the temozolomide era: have we improved outcome?. J Neurooncol. 2013;115(2):303-310.
-
(2013)
J Neurooncol
, vol.115
, Issue.2
, pp. 303-310
-
-
Lwin, Z.1
MacFadden, D.2
Al-Zahrani, A.3
-
11
-
-
84861328546
-
Improved survival time trends for glioblastoma using the SEER 17 population-based registries
-
Koshy M, Villano JL, Dolecek TA, et al. Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neurooncol. 2012;107(1):207-212.
-
(2012)
J Neurooncol
, vol.107
, Issue.1
, pp. 207-212
-
-
Koshy, M.1
Villano, J.L.2
Dolecek, T.A.3
-
12
-
-
85047052863
-
Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide (TMZ) therapy for high-grade gliomas (HGG) in Colombia (RedLANO registry)
-
Ortiz LD, Cardona AF, Fadul CE, et al. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide (TMZ) therapy for high-grade gliomas (HGG) in Colombia (RedLANO registry). ASCO Meeting Abstracts. 2011;29(15_suppl):2092.
-
(2011)
ASCO Meeting Abstracts
, vol.29
, Issue.15
, pp. 2092
-
-
Ortiz, L.D.1
Cardona, A.F.2
Fadul, C.E.3
-
13
-
-
84881536183
-
Brain tumor epidemiology in Austria and the Austrian Brain Tumor Registry
-
Woehrer A. Brain tumor epidemiology in Austria and the Austrian Brain Tumor Registry. Clin Neuropathol. 2013;32(4):269-285.
-
(2013)
Clin Neuropathol
, vol.32
, Issue.4
, pp. 269-285
-
-
Woehrer, A.1
-
14
-
-
20344407807
-
Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas
-
Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol. 2005;64(6):479-489.
-
(2005)
J Neuropathol Exp Neurol
, vol.64
, Issue.6
, pp. 479-489
-
-
Ohgaki, H.1
Kleihues, P.2
-
15
-
-
84857061372
-
Patterns of care and survival for glioblastoma patients in the Veterans population
-
Arrigo RT, Boakye M, Skirboll SL. Patterns of care and survival for glioblastoma patients in the Veterans population. J Neurooncol. 2011;106(3):627-635.
-
(2011)
J Neurooncol
, vol.106
, Issue.3
, pp. 627-635
-
-
Arrigo, R.T.1
Boakye, M.2
Skirboll, S.L.3
-
16
-
-
84886515453
-
High procedure volume is strongly associated with improved survival after lung cancer surgery
-
Luchtenborg M, Riaz SP, Coupland VH, et al. High procedure volume is strongly associated with improved survival after lung cancer surgery. J Clin Oncol. 2013;31(25):3141-3146.
-
(2013)
J Clin Oncol
, vol.31
, Issue.25
, pp. 3141-3146
-
-
Luchtenborg, M.1
Riaz, S.P.2
Coupland, V.H.3
-
17
-
-
0036037267
-
The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer
-
Martling A, Cedermark B, Johansson H, et al. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br J Surg. 2002;89(8): 1008-1013.
-
(2002)
Br J Surg
, vol.89
, Issue.8
, pp. 1008-1013
-
-
Martling, A.1
Cedermark, B.2
Johansson, H.3
-
18
-
-
84879072261
-
Adherence to treatment guidelines for ovarian cancer as a measure of quality care
-
Bristow RE, Chang J, Ziogas A, et al. Adherence to treatment guidelines for ovarian cancer as a measure of quality care. Obstet Gynecol. 2013;121(6):1226-1234.
-
(2013)
Obstet Gynecol
, vol.121
, Issue.6
, pp. 1226-1234
-
-
Bristow, R.E.1
Chang, J.2
Ziogas, A.3
-
19
-
-
84875418001
-
Hospital and Surgeon Volume in Relation to Survival After Esophageal Cancer Surgery in a Population-Based Study
-
Derogar M, Sadr-Azodi O, Johar A, et al. Hospital and Surgeon Volume in Relation to Survival After Esophageal Cancer Surgery in a Population-Based Study. J Clin Oncol. 2013;31(5):551-557.
-
(2013)
J Clin Oncol
, vol.31
, Issue.5
, pp. 551-557
-
-
Derogar, M.1
Sadr-Azodi, O.2
Johar, A.3
|